The trademark application DEWPOINTX was filed by Dewpoint Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on February 14, 2021, and it was registered by office on May 24, 2021 without any oppositions.
The application was filed in English (Italian was selected as the second language).
Change of name and professional address of the trademark registration was recorded on October 11, 2023. Appointment and Replacement of representative of the trademark registration was recorded on August 14, 2024.
Goods And Services
The mark was filed in class 1 with following description of goods:
Reagents for research use
Reagents for research purposes of drug discovery and development
Reagents for clinical use.
The mark was filed in class 5 with Pharmaceutical preparations and therapeutic agents for use in the treatment and prevention of neurodegenerative diseases, cancer, metabolic disease, auto-immune diseases, inflammation, infectious disease, prion-based diseases, cardiovascular diseases, women's health in the nature of uterine fibroids and Polycystic Ovary Syndrome (PCOS), renal disease, pulmonary diseases, neurological disease, fibrosis, liver diseases and wound healing and reagents for medical use..